Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Advanced GIST
NCT01440959Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Sep 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Started Sep 2011; status: completed.
02
Drugs
dovitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01440959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440959.